rs6265
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
|
31771052 |
2020 |
rs6265
|
|
|
0.070 |
GeneticVariation |
BEFREE |
A total of 1,081 adults without dementia (375 healthy subjects and 706 individuals with mild cognitive impairment) were recruited from the Alzheimer's Disease Neuroimaging Initiative (ADNI) to test the influence of BDNF Val66Met polymorphism on cognitive impairment, brain structure atrophy, and change in the levels of CSF biomarkers.
|
30775992 |
2019 |
rs6265
|
|
|
0.070 |
GeneticVariation |
BEFREE |
To compare the results of neuropsychological tests, evoked potentials N200 and P300 and polymorphisms of ApoE and BDNF rs6265 between patients with normal cognition and those with mild cognitive impairment (MCI) and Alzheimer's dementia (AD).
|
28833437 |
2018 |
rs6265
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Physical exercise improves peripheral BDNF levels and cognitive functions in mild cognitive impairment elderly with different bdnf Val66Met genotypes.
|
25062900 |
2015 |
rs6265
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease.
|
22699449 |
2012 |
rs6265
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Although Val66Met polymorphisms were not associated with the cross-sectional diagnoses of MCI or AD, the presence of Met-BDNF allele was associated with a higher risk of disease-progression in patients with MCI (OR=3.0 CI(95%) [1.2-7.8], P=0.02).
|
20491609 |
2010 |
rs6265
|
|
|
0.070 |
GeneticVariation |
BEFREE |
The BDNF Val66Met polymorphism was not associated with serum BDNF or cognitive function in aMCI patients.
|
18505307 |
2008 |
rs759834365
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
|
31771052 |
2020 |
rs759834365
|
|
|
0.060 |
GeneticVariation |
BEFREE |
A total of 1,081 adults without dementia (375 healthy subjects and 706 individuals with mild cognitive impairment) were recruited from the Alzheimer's Disease Neuroimaging Initiative (ADNI) to test the influence of BDNF Val66Met polymorphism on cognitive impairment, brain structure atrophy, and change in the levels of CSF biomarkers.
|
30775992 |
2019 |
rs759834365
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Physical exercise improves peripheral BDNF levels and cognitive functions in mild cognitive impairment elderly with different bdnf Val66Met genotypes.
|
25062900 |
2015 |
rs759834365
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease.
|
22699449 |
2012 |
rs759834365
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Although Val66Met polymorphisms were not associated with the cross-sectional diagnoses of MCI or AD, the presence of Met-BDNF allele was associated with a higher risk of disease-progression in patients with MCI (OR=3.0 CI(95%) [1.2-7.8], P=0.02).
|
20491609 |
2010 |
rs759834365
|
|
|
0.060 |
GeneticVariation |
BEFREE |
The BDNF Val66Met polymorphism was not associated with serum BDNF or cognitive function in aMCI patients.
|
18505307 |
2008 |
rs1451603364
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We aimed to investigate the roles of RAGE, AGEs and the Gly82Ser polymorphism of RAGE in mild cognitive impairment (MCI) among type 2 diabetes patients.
|
26745632 |
2016 |